How should we view the results of the Multicenter Selective Lymphadenectomy Trial-1 (MSLT-1)?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed.

1. External validation of the Melanoma Institute Australia Sentinel Node Metastasis Risk Prediction Tool using the National Cancer Database.Journal of the American Academy of Dermatology · 2023
   Article
2. Melanoma & nuclear medicine: new insights & advances.Melanoma management · 2018
   Review
3. Impact of Completion Lymph Node Dissection on Patients with Positive Sentinel Lymph Node Biopsy in Melanoma.Journal of the American College of Surgeons · 2016
   Article
4. Melanoma and nuclear medicine.Melanoma management · 2014
   Review
5. Sentinel lymph node status as most important prognostic factor in patients with high-risk cutaneous melanomas (tumour thickness >4.00 mm): outcome analysis from a single institution.European journal of nuclear medicine and molecular imaging · 2012
   Article
6. Prognostic value of sentinel lymph node biopsy in 121 low-risk melanomas (tumour thickness <1.00 mm) on the basis of a long-term follow-up.European journal of nuclear medicine and molecular imaging · 2012
   Article
7. Risk evaluation in cutaneous melanoma patients undergoing lymph node dissection: impact of POSSUM.Annals of the Royal College of Surgeons of England · 2011
   Article
8. Importance of tumor load in the sentinel node in melanoma: clinical dilemmas.Nature reviews. Clinical oncology · 2010
   Review
9. Sentinel node biopsy needs for a suitable therapeutic management of the cutaneous melanoma.Nature clinical practice. Oncology · 2009
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as